Month: <span>September 2025</span>
Month: September 2025

Clinical Utility of miR-590-5p as a Biomarker for Stratifying Disease Severity and Anticipating Adverse Perinatal Outcomes in Preeclamptic Patients

Am J Hypertens. 2025 Sep 20:hpaf191. doi: 10.1093/ajh/hpaf191. Online ahead of print. ABSTRACT BACKGROUND: Chronic hypertension, gestational hypertension (GH), and preeclampsia (PE) together comprise hypertensive …

Use of Continuous Glucose Monitors in Publicly Insured Youth With Type 2 Diabetes: A 12-month Pilot and Feasibility Study

J Diabetes Sci Technol. 2025 Sep 20:19322968251368366. doi: 10.1177/19322968251368366. Online ahead of print. ABSTRACT BACKGROUND: Type 2 diabetes (T2D) disproportionately affects youth with public insurance …

Investigation of Infection Risk Associated with Janus Kinase Inhibitors: A Pharmacovigilance Analysis Using the Food and Drug Administration’s Adverse Event Reporting System Database

Clin Exp Dermatol. 2025 Sep 20:llaf427. doi: 10.1093/ced/llaf427. Online ahead of print. ABSTRACT BACKGROUND: The use of JAK inhibitors (JAKis) is growing in dermatology with …

Caregivers’ Perspectives on Changes in Family Life During B-ALL Therapy: A Qualitative Study From the Children’s Oncology Group

Pediatr Blood Cancer. 2025 Sep 19:e32057. doi: 10.1002/pbc.32057. Online ahead of print. ABSTRACT BACKGROUND: Treatment of pediatric B-acute lymphoblastic leukemia (B-ALL) impacts both patients and …